Research Article

Calpain Small Subunit 1 Protein in the Prognosis of Cancer Survivors and Its Clinicopathological Correlation

Table 1

Characteristics of eligible studies in this meta-analysis.

Author, YearCancer typeTotal numberCalpain-4 protein expressionJudgment standards for high Capn4 expressionOutcome measuresFollow-upsAnalysisHR (95%CI) for OSHR (95%CI) for DFS/PFS/RFSNOS
H/PL/N

Cheng F, 2018CRC1328745Each specimen was scored for the extent of stained cells (0-1% = 0, 1~24% =1, 25~49% =2, 50~74% =3, 75~100% =4). A value ≥2 as a high score.OS, DFS≥5 yearsUVA1.91 (1.21-2.78)1.85 (1.12-2.39)6

Wu XX, 2018ESCC15510550The final score was obtained by multiplying the ratio of positive cells score and the intensity score, and a final score of 8-12 was classified as high expression.OS≥5 yearsMVA1.68 (1.05-3.97)NR7

Yang MF, 2018OC1136053The final scores of Capn4 expression,
ranging from 0 to 9, were calculated by multiplying the percentage score by the intensity score. A final score of ≥4 was classified as high expression.
OS, PFS≥5 yearsMVA2.16 (1.09-3.14)2.04 (1.28-3.27)7

Yang X, 2017OC916823The staining index was evaluated by multiplying the score of staining intensity and the percentage of positive tumor cells, samples with an SI ≥8 were defined as showing high expression.OS≥5 yearsUVA1.62 (1.10-2.37)NR6

Peng P, 2016GC17410272Composite expression scores = 4 (intensity score−1) + frequency score.
CES of calpain-4 greater than or equal to 6 were considered to be high expression.
OS≥5 yearsMVA1.98 (1.16-3.38)NR8

Zhang C, 2013ICC1408060Capn4 high: the mean area of positive
staining>50% of the tumor section.
OS, RFS≥5 yearsMVA1.66 (1.12-2.46)1.49 (1.01-2.21)7

Zheng PC, 2014NPC1537261The scores of 0, 1-2, 3-4, and 5-6 were considered to be negative, low, medium, and strong, respectively. The scores of 5–6 were considered to be high.OS, PFS≥5 yearsUVA1.56 (1.04-3.01)1.63 (1.11-3.08)7

Gu J, 2015NSCLC20811197The intensity of Capn4 was classified into four grades (0 for negative; 1 for weak; 2 for moderate; and 3 for strong). Scores of 2 or 3 were considered Capn4 high.OS≥5 yearsMVA1.53 (1.04-2.25)NR8

Bai DS, 2009HCC19270122The final score of each sample was assessed by summarizing the result of intensity and extent of staining. The case was considered positive if the final score was
4 to 5 (+) or 6 to 7 (++).
OS, RFS≥5 yearsMVA4.07 (2.52-6.55)46.95 (13.96-157.93)8

Cai JJ, 2014GBM945242A positive reaction for Capn4 was classified into four grades (0 for negative; 1 for weak; 2 for moderate; and 3 for strong). The moderate or strong intensity was classified as high Capn4 expression.OS, PFS≥5 yearsMVA1.54 (1.00-2.06)1.83 (1.17-2.85)6

Dai Z, 2014HCC323161162NROS≥5 yearsMVA1.87 (1.35-2.60)NR8

CRC: colorectal cancer; ESCC: esophageal squamous cell carcinoma; OC: ovarian cancer; ICC: intrahepatic cholangiocarcinoma; NPC: nasopharyngeal carcinoma; NSCLC: non-small cell lung cancer; GBM: glioblastoma; HCC: hepatocellular carcinoma; IHC: immunohistochemistry; H/P: high/positive expression; L/N: low/negative expression; OS: overall survival; DFS: disease-free survival; RFS: recurrence-free survival; PFS: progression-free survival; UVA: univariate analysis; MVA: multivariate analysis; SI: staining index; CES: composite expression scores; NR: not reported.